BIAFW - Balance Sheet - bioAffinity Technologies, Inc.

Current Liabilities	3.1 M
Accounts Payable	987 K
Short-Term Debt	694 K
Other Current Liabilities	1.42 M
Non-Current Liabilities	807 K
Long-Term Debt	20.2 K
Other Non-Current Liabilities	787 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	1.1	2.8	11.4	1.4	83.1 K	0.6
Short Term Investments	0	0	0	0	0	0
Receivables	1.1	0.8	10.5 K	1.53 K	1.53 K	1.53 K
Inventory	27.6 K	18.5 K	5.54 K	71.8 K	28.4 K	0
Other Current Assets	0.4	0.3	0.5	76.1 K	34 K	37.5 K
Total Current Assets	2.7	4.0	12.0	1.4	0.1	0.6
PP&E	1.6	2.0	0.2	4.63 K	9.45 K	28.8 K
Intangible Assets	0.8	0.8	0	0	0	0
Goodwill	1.4	1.4	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	19.7 K	16.1 K	6 K	10.4 K	17.5 K	12.5 K
Other Assets	0	0	0	0	0	0
Total Assets	6.5	8.2	12.2	1.5	0.1	0.7
LIABILITIES
Accounts Payable	1.0	0.6	0.3	0.2	0.2	0.1
Short Term Debt	0.7	0.5	0.3	11.2	10.0	4.0
Other Current Liabilities	1.4	1.1	0.5	1.6	1.0	0.6
Total Current Liabilities	3.1	2.2	1.1	13.0	11.1	4.7
Long Term Debt	20.2 K	1.1	0	0.2	53.5 K	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0.8	0	0	4.0	4.0	0
Total Liabilities	3.9	3.4	1.1	17.2	15.2	4.7
EQUITY
Common Stock	0.1	65.8 K	58.7 K	18.7 K	18.7 K	18.7 K
Retained Earnings	(53.6)	(44.6)	(36.7)	(28.5)	(22.2)	(14.9)
Other Accumulative Comprehensive Income/Loss	0	0	0	(4.0)	(4.0)	18.7 K
Total Equity	2.6	4.9	11.0	(15.8)	(15.1)	(4.0)
Total Liabilities and Equity	6.5	8.2	12.2	1.5	0.1	0.7
SHARES OUTSTANDING
Common Shares Outstanding	12.1	8.7	4.5	7.4	7.4	7.4

Free